Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
The IL-2 receptor alpha-chain alters the binding of IL-2 to the beta-chainN Arima, M Kamio, M Okuma, et al.
Biochemical Pharmacology|January 22, 1992
Irreversible inhibition of thromboxane (TX) A2 synthesis by Y-20811, a selective TX synthetase inhibitorH Mikashima, H Ochi, Y Muramoto, et al.
Virology|August 11, 2000
Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemiaM Makino, S Wakamatsu, S Shimokubo, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeastA Tanimoto, Y Ide, N Arima, et al.
The Journal of Biological Chemistry|August 7, 1999
Transactivation of the human cdc2 promoter by adenovirus E1A. E1A induces the expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding proteinC Y Kao, A Tanimoto, N Arima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expressionN Arima, W A Kuziel, T A Grdina, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1995
[Successful adjuvant therapy of M-CSF with chemotherapy of two cases of chemotherapy resistant acute promyelocytic leukemia]K Matsushita, T Matsumoto, N Arima, et al.
Pathology International|March 1, 1996
Endometrial stromal sarcoma of the uterus with rhabdoid featuresA Tanimoto, T Sasaguri, N Arima, et al.
Biochemical and Biophysical Research Communications|May 15, 1992
The third molecule associated with interleukin 2 receptor alpha and beta chainM Kamio, N Arima, M Tsudo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 1999
[Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma]N Arima, H Mizoguchi, S Shirakawa, et al.
Pageof 12